# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Apr 4, 2025

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2025-04-04
- Accepted by EDGAR: Apr 4, 2025, 16:05 ET
- Period: 2025-04-04
- Accession: 0001104659-25-032189
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925032189/tm2511590d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465925032189/

## Items reported

- Item 3.03: Change to security holders’ rights

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465925032189/tm2511590d1_8k.htm

Filed Apr 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-032189. Last ingested by Listed: Oct 26, 2026, 20:22 ET. No prices; not investment advice.